EA023565B1 - Способы и композиции для неинвазивной пренатальной диагностики анеуплоидии плода - Google Patents
Способы и композиции для неинвазивной пренатальной диагностики анеуплоидии плода Download PDFInfo
- Publication number
- EA023565B1 EA023565B1 EA201290716A EA201290716A EA023565B1 EA 023565 B1 EA023565 B1 EA 023565B1 EA 201290716 A EA201290716 A EA 201290716A EA 201290716 A EA201290716 A EA 201290716A EA 023565 B1 EA023565 B1 EA 023565B1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- base pairs
- dna
- sample
- hypermethylated
- dmu
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 117
- 230000001605 fetal effect Effects 0.000 title claims abstract description 71
- 208000036878 aneuploidy Diseases 0.000 title claims abstract description 40
- 231100001075 aneuploidy Toxicity 0.000 title claims abstract description 40
- 239000000203 mixture Substances 0.000 title claims abstract description 29
- 238000003793 prenatal diagnosis Methods 0.000 title claims abstract description 19
- 210000004369 blood Anatomy 0.000 claims abstract description 60
- 239000008280 blood Substances 0.000 claims abstract description 60
- 230000008774 maternal effect Effects 0.000 claims abstract description 44
- 238000001114 immunoprecipitation Methods 0.000 claims abstract description 18
- 108020004414 DNA Proteins 0.000 claims description 424
- 210000000349 chromosome Anatomy 0.000 claims description 304
- 201000010374 Down Syndrome Diseases 0.000 claims description 121
- 206010044688 Trisomy 21 Diseases 0.000 claims description 119
- 230000006607 hypermethylation Effects 0.000 claims description 87
- 210000005259 peripheral blood Anatomy 0.000 claims description 78
- 239000011886 peripheral blood Substances 0.000 claims description 78
- 238000011529 RT qPCR Methods 0.000 claims description 37
- 238000000926 separation method Methods 0.000 claims description 32
- 238000003752 polymerase chain reaction Methods 0.000 claims description 29
- 108091034117 Oligonucleotide Proteins 0.000 claims description 26
- 238000003745 diagnosis Methods 0.000 claims description 25
- 239000003155 DNA primer Substances 0.000 claims description 21
- 230000003321 amplification Effects 0.000 claims description 20
- 230000008859 change Effects 0.000 claims description 20
- 239000000126 substance Substances 0.000 claims description 19
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 18
- 208000037280 Trisomy Diseases 0.000 claims description 18
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 18
- 108020004707 nucleic acids Proteins 0.000 claims description 18
- 102000039446 nucleic acids Human genes 0.000 claims description 18
- 150000007523 nucleic acids Chemical class 0.000 claims description 18
- 238000003776 cleavage reaction Methods 0.000 claims description 16
- 230000002255 enzymatic effect Effects 0.000 claims description 16
- 230000007017 scission Effects 0.000 claims description 16
- 238000003753 real-time PCR Methods 0.000 claims description 13
- 230000001404 mediated effect Effects 0.000 claims description 10
- 239000012133 immunoprecipitate Substances 0.000 claims description 4
- 230000035935 pregnancy Effects 0.000 abstract description 28
- 239000000523 sample Substances 0.000 description 187
- 230000011987 methylation Effects 0.000 description 97
- 238000007069 methylation reaction Methods 0.000 description 97
- 210000002826 placenta Anatomy 0.000 description 74
- 210000003754 fetus Anatomy 0.000 description 64
- 239000013615 primer Substances 0.000 description 60
- 238000012360 testing method Methods 0.000 description 48
- 230000003169 placental effect Effects 0.000 description 42
- 238000004458 analytical method Methods 0.000 description 40
- 238000002405 diagnostic procedure Methods 0.000 description 28
- 238000006243 chemical reaction Methods 0.000 description 23
- 108090000623 proteins and genes Proteins 0.000 description 23
- 239000011159 matrix material Substances 0.000 description 20
- 230000007067 DNA methylation Effects 0.000 description 15
- 238000007619 statistical method Methods 0.000 description 15
- 239000012634 fragment Substances 0.000 description 14
- 238000010606 normalization Methods 0.000 description 12
- 238000010200 validation analysis Methods 0.000 description 11
- 238000010586 diagram Methods 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 10
- 230000002093 peripheral effect Effects 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 239000000872 buffer Substances 0.000 description 8
- 238000011161 development Methods 0.000 description 8
- 230000035945 sensitivity Effects 0.000 description 8
- 230000002159 abnormal effect Effects 0.000 description 7
- 239000002773 nucleotide Substances 0.000 description 7
- 125000003729 nucleotide group Chemical group 0.000 description 7
- 108091008146 restriction endonucleases Proteins 0.000 description 7
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 101150036708 NUR1 gene Proteins 0.000 description 5
- 239000008186 active pharmaceutical agent Substances 0.000 description 5
- 230000000875 corresponding effect Effects 0.000 description 5
- 230000001419 dependent effect Effects 0.000 description 5
- 238000013467 fragmentation Methods 0.000 description 5
- 238000006062 fragmentation reaction Methods 0.000 description 5
- 238000009396 hybridization Methods 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 238000002604 ultrasonography Methods 0.000 description 5
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 4
- 102000012410 DNA Ligases Human genes 0.000 description 4
- 108010061982 DNA Ligases Proteins 0.000 description 4
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 3
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 3
- 238000002669 amniocentesis Methods 0.000 description 3
- 229960002685 biotin Drugs 0.000 description 3
- 235000020958 biotin Nutrition 0.000 description 3
- 239000011616 biotin Substances 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 210000004252 chorionic villi Anatomy 0.000 description 3
- 230000002759 chromosomal effect Effects 0.000 description 3
- 238000007405 data analysis Methods 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 230000001973 epigenetic effect Effects 0.000 description 3
- 238000007854 ligation-mediated PCR Methods 0.000 description 3
- 230000007170 pathology Effects 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- LRSASMSXMSNRBT-UHFFFAOYSA-N 5-methylcytosine Chemical compound CC1=CNC(=O)N=C1N LRSASMSXMSNRBT-UHFFFAOYSA-N 0.000 description 2
- 108090001008 Avidin Proteins 0.000 description 2
- 230000004544 DNA amplification Effects 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 208000036818 High risk pregnancy Diseases 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 108010090804 Streptavidin Proteins 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000004422 calculation algorithm Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000006862 enzymatic digestion Effects 0.000 description 2
- 231100000562 fetal loss Toxicity 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000011859 microparticle Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000012521 purified sample Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000007363 ring formation reaction Methods 0.000 description 2
- 238000013207 serial dilution Methods 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 238000010972 statistical evaluation Methods 0.000 description 2
- 238000000528 statistical test Methods 0.000 description 2
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 101100366946 Arabidopsis thaliana STOP1 gene Proteins 0.000 description 1
- 240000005528 Arctium lappa Species 0.000 description 1
- 230000006429 DNA hypomethylation Effects 0.000 description 1
- 230000007018 DNA scission Effects 0.000 description 1
- 208000036626 Mental retardation Diseases 0.000 description 1
- 244000004005 Nypa fruticans Species 0.000 description 1
- 235000005305 Nypa fruticans Nutrition 0.000 description 1
- 235000008753 Papaver somniferum Nutrition 0.000 description 1
- 241000218180 Papaveraceae Species 0.000 description 1
- 241000036848 Porzana carolina Species 0.000 description 1
- 208000005107 Premature Birth Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000002547 anomalous effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 239000012148 binding buffer Substances 0.000 description 1
- 238000004159 blood analysis Methods 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000002559 cytogenic effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- WBZKQQHYRPRKNJ-UHFFFAOYSA-L disulfite Chemical compound [O-]S(=O)S([O-])(=O)=O WBZKQQHYRPRKNJ-UHFFFAOYSA-L 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 210000003917 human chromosome Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000005291 magnetic effect Effects 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 208000030454 monosomy Diseases 0.000 description 1
- FTTNHUULIMOCKS-WAYWQWQTSA-N n-[(z)-3-acetamidobut-2-en-2-yl]acetamide Chemical compound CC(=O)N\C(C)=C(\C)NC(C)=O FTTNHUULIMOCKS-WAYWQWQTSA-N 0.000 description 1
- QNILTEGFHQSKFF-UHFFFAOYSA-N n-propan-2-ylprop-2-enamide Chemical compound CC(C)NC(=O)C=C QNILTEGFHQSKFF-UHFFFAOYSA-N 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000005298 paramagnetic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 201000011461 pre-eclampsia Diseases 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000009598 prenatal testing Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000010187 selection method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000005549 size reduction Methods 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6804—Nucleic acid analysis using immunogens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29833910P | 2010-01-26 | 2010-01-26 | |
| US40542110P | 2010-10-21 | 2010-10-21 | |
| PCT/IB2011/000217 WO2011092592A2 (en) | 2010-01-26 | 2011-01-26 | Methods and compositions for noninvasive prenatal diagnosis of fetal aneuploidies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA201290716A1 EA201290716A1 (ru) | 2013-06-28 |
| EA023565B1 true EA023565B1 (ru) | 2016-06-30 |
Family
ID=44278821
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201290716A EA023565B1 (ru) | 2010-01-26 | 2011-01-26 | Способы и композиции для неинвазивной пренатальной диагностики анеуплоидии плода |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US9249462B2 (enExample) |
| EP (1) | EP2529032B1 (enExample) |
| JP (1) | JP2013517789A (enExample) |
| KR (1) | KR20120107512A (enExample) |
| CN (1) | CN102892899A (enExample) |
| AU (1) | AU2011210255B2 (enExample) |
| BR (1) | BR112012018458A2 (enExample) |
| CA (1) | CA2786174A1 (enExample) |
| CY (1) | CY1118864T1 (enExample) |
| DK (1) | DK2529032T3 (enExample) |
| EA (1) | EA023565B1 (enExample) |
| ES (1) | ES2623156T3 (enExample) |
| NZ (1) | NZ601079A (enExample) |
| PL (1) | PL2529032T3 (enExample) |
| PT (1) | PT2529032T (enExample) |
| SG (1) | SG182322A1 (enExample) |
| WO (1) | WO2011092592A2 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018129293A1 (en) * | 2017-01-05 | 2018-07-12 | Diacarta Llc | Method for conducting early detection of colon cancer and/or of colon cancer precursor cells and for monitoring colon cancer recurrence |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101153336B (zh) | 2006-09-27 | 2011-09-07 | 香港中文大学 | 检测dna甲基化程度的方法和试剂盒 |
| US8476013B2 (en) | 2008-09-16 | 2013-07-02 | Sequenom, Inc. | Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses |
| US8962247B2 (en) | 2008-09-16 | 2015-02-24 | Sequenom, Inc. | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses |
| EP2516680B1 (en) | 2009-12-22 | 2016-04-06 | Sequenom, Inc. | Processes and kits for identifying aneuploidy |
| US9605313B2 (en) | 2012-03-02 | 2017-03-28 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| US9920361B2 (en) | 2012-05-21 | 2018-03-20 | Sequenom, Inc. | Methods and compositions for analyzing nucleic acid |
| US10504613B2 (en) | 2012-12-20 | 2019-12-10 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| EP2872648B1 (en) | 2012-07-13 | 2019-09-04 | Sequenom, Inc. | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses |
| US9732390B2 (en) | 2012-09-20 | 2017-08-15 | The Chinese University Of Hong Kong | Non-invasive determination of methylome of fetus or tumor from plasma |
| US10706957B2 (en) | 2012-09-20 | 2020-07-07 | The Chinese University Of Hong Kong | Non-invasive determination of methylome of tumor from plasma |
| FI4056712T3 (fi) * | 2012-09-20 | 2024-08-29 | Univ Hong Kong Chinese | Kasvaimen metyloomin nonivasiivinen määrittäminen plasmasta |
| CN104838013A (zh) * | 2012-09-26 | 2015-08-12 | 新加坡科技研究局 | 用于唐氏综合症产前诊断的生物标志物 |
| EP3597774A1 (en) | 2013-03-13 | 2020-01-22 | Sequenom, Inc. | Primers for dna methylation analysis |
| KR20140118682A (ko) | 2013-03-29 | 2014-10-08 | (주)셀트리온 | 2 이상의 인플루엔자 ａ 바이러스 중화 결합 분자를 포함하는 조성물 |
| EP3117011B1 (en) | 2014-03-13 | 2020-05-06 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| RU2583830C2 (ru) * | 2014-04-21 | 2016-05-10 | Закрытое акционерное общество "Геноаналитика" | Способ неинвазивной пренатальной диагностики анеуплоидий плода |
| EP2942401A1 (en) | 2014-05-09 | 2015-11-11 | Lifecodexx AG | Detection of DNA that originates from a specific cell-type |
| EP2942400A1 (en) | 2014-05-09 | 2015-11-11 | Lifecodexx AG | Multiplex detection of DNA that originates from a specific cell-type |
| EP3521454A1 (en) | 2014-05-09 | 2019-08-07 | LifeCodexx AG | Detection of dna that originates from a specific cell-type and related methods |
| US10174383B2 (en) * | 2014-08-13 | 2019-01-08 | Vanadis Diagnostics | Method of estimating the amount of a methylated locus in a sample |
| WO2016176846A1 (zh) * | 2015-05-06 | 2016-11-10 | 安诺优达基因科技(北京)有限公司 | 检测染色体非整倍性的试剂盒、装置和方法 |
| WO2016189388A1 (en) | 2015-05-22 | 2016-12-01 | Nipd Genetics Ltd | Multiplexed parallel analysis of targeted genomic regions for non-invasive prenatal testing |
| DK3168309T3 (da) | 2015-11-10 | 2020-06-22 | Eurofins Lifecodexx Gmbh | Detektion af føtale kromosomale aneuploidier under anvendelse af dna-regioner med forskellig metylering mellem fosteret og det gravide hunkøn |
| SG11201804651XA (en) * | 2015-12-04 | 2018-07-30 | Green Cross Genome Corp | Method for determining copy-number variation in sample comprising mixture of nucleic acids |
| KR101817180B1 (ko) * | 2016-01-20 | 2018-01-10 | 이원다이애그노믹스(주) | 염색체 이상 판단 방법 |
| US10781490B2 (en) | 2016-05-30 | 2020-09-22 | The Chinese University Of Hong Kong | Detecting hematological disorders using cell-free DNA in blood |
| CN109112209B (zh) * | 2017-06-25 | 2022-06-24 | 国家卫生计生委科学技术研究所 | 用于无创产前检测胎儿非整倍体染色体的参考品 |
| US12027237B2 (en) | 2018-03-13 | 2024-07-02 | Grail, Llc | Anomalous fragment detection and classification |
| KR20200060969A (ko) | 2018-11-23 | 2020-06-02 | (주)셀트리온 | 인플루엔자 바이러스 질환을 치료하기 위한 투여 요법 |
| US12234514B2 (en) | 2018-12-21 | 2025-02-25 | Grail, Inc. | Source of origin deconvolution based on methylation fragments in cell-free DNA samples |
| US20230151409A1 (en) * | 2020-03-30 | 2023-05-18 | Vilnius University | Methods and compositions for noninvasive prenatal diagnosis through targeted covalent labeling of genomic sites |
| KR102332540B1 (ko) * | 2020-07-02 | 2021-11-29 | 의료법인 성광의료재단 | 다운증후군 특이적인 후성학적 마커를 이용한 다운증후군 진단 방법 |
| US20250079015A1 (en) * | 2022-01-10 | 2025-03-06 | Washington State University | Dna methylation biomarkers for preterm birth |
| WO2024216205A1 (en) * | 2023-04-14 | 2024-10-17 | Adela, Inc. | Methods and systems for cell-free nucleic acid processing |
| WO2025179073A1 (en) * | 2024-02-21 | 2025-08-28 | Adela, Inc. | Methods and systems for tissue informed differentially methylated region analysis |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005028674A2 (en) * | 2003-09-22 | 2005-03-31 | Trisogen Biotechnology Limited Partnership | Methods and kits useful for detecting an alteration in a locus copy number |
| WO2007007337A1 (en) * | 2005-07-13 | 2007-01-18 | Trisogen Biotechnology Limited Partnership | Methods and kits useful for detecting an alteration in a locus copy number |
| WO2007044780A2 (en) * | 2005-10-07 | 2007-04-19 | Emory University | Methods and systems for screening for and diagnosing dna methylation associated abnormalities and sex chromosome aneuploidies |
| WO2007132167A2 (en) * | 2006-05-03 | 2007-11-22 | The Chinese University Of Hong Kong | Novel fetal markers for prenatal diagnosis and monitoring |
| US20100105049A1 (en) * | 2008-09-16 | 2010-04-29 | Sequenom, Inc. | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6582908B2 (en) * | 1990-12-06 | 2003-06-24 | Affymetrix, Inc. | Oligonucleotides |
| GB0413688D0 (en) | 2004-06-18 | 2004-07-21 | Novartis Forschungsstiftung | Analysis of methylated nucleic acid |
| AU2005308918B2 (en) | 2004-11-29 | 2012-09-27 | Sequenom, Inc. | Means and methods for detecting methylated DNA |
| EP3892736A1 (en) | 2007-07-23 | 2021-10-13 | The Chinese University of Hong Kong | Determining a nucleic acid sequence imbalance |
| JP5322471B2 (ja) | 2008-03-27 | 2013-10-23 | シスメックス株式会社 | メチル化ｄｎａの解析方法及びプライマーセット |
-
2011
- 2011-01-26 NZ NZ601079A patent/NZ601079A/en unknown
- 2011-01-26 AU AU2011210255A patent/AU2011210255B2/en active Active
- 2011-01-26 EP EP11709465.6A patent/EP2529032B1/en active Active
- 2011-01-26 CN CN2011800097571A patent/CN102892899A/zh active Pending
- 2011-01-26 PT PT117094656T patent/PT2529032T/pt unknown
- 2011-01-26 ES ES11709465.6T patent/ES2623156T3/es active Active
- 2011-01-26 KR KR1020127020832A patent/KR20120107512A/ko not_active Withdrawn
- 2011-01-26 EA EA201290716A patent/EA023565B1/ru not_active IP Right Cessation
- 2011-01-26 DK DK11709465.6T patent/DK2529032T3/en active
- 2011-01-26 PL PL11709465T patent/PL2529032T3/pl unknown
- 2011-01-26 CA CA2786174A patent/CA2786174A1/en not_active Abandoned
- 2011-01-26 JP JP2012550529A patent/JP2013517789A/ja active Pending
- 2011-01-26 SG SG2012049003A patent/SG182322A1/en unknown
- 2011-01-26 BR BR112012018458A patent/BR112012018458A2/pt not_active IP Right Cessation
- 2011-01-26 US US13/520,708 patent/US9249462B2/en active Active
- 2011-01-26 WO PCT/IB2011/000217 patent/WO2011092592A2/en not_active Ceased
-
2017
- 2017-04-21 CY CY20171100452T patent/CY1118864T1/el unknown
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005028674A2 (en) * | 2003-09-22 | 2005-03-31 | Trisogen Biotechnology Limited Partnership | Methods and kits useful for detecting an alteration in a locus copy number |
| WO2007007337A1 (en) * | 2005-07-13 | 2007-01-18 | Trisogen Biotechnology Limited Partnership | Methods and kits useful for detecting an alteration in a locus copy number |
| WO2007044780A2 (en) * | 2005-10-07 | 2007-04-19 | Emory University | Methods and systems for screening for and diagnosing dna methylation associated abnormalities and sex chromosome aneuploidies |
| WO2007132167A2 (en) * | 2006-05-03 | 2007-11-22 | The Chinese University Of Hong Kong | Novel fetal markers for prenatal diagnosis and monitoring |
| US20100105049A1 (en) * | 2008-09-16 | 2010-04-29 | Sequenom, Inc. | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses |
Non-Patent Citations (6)
| Title |
|---|
| DATABASE MEDLINE [Online], US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; August 2007 (2007-08), OLD ROBERT W. ET AL.: "Candidate epigenetic biomarkers for non-invasive prenatal diagnosis of Down syndrome", XP002653418, Database accession no. NLM17697502, abstract * |
| GO A.T.J. I. ET AL.: "Non-invasive aneuploidy detection using free fetal DNA and RNA in maternal plasma: Recent progress and future possibilities", HUMAN REPRODUCTION UPDATE, vol. 17, no. 3, 12 November 2010 (2010-11-12), XP002653421, OXFORD UNIVERSITY PRESS GBR DOI: 10.1093/HUMUPD/DMQ054 Retrieved from the Internet: URL:http://humupd.oxfordjournals.org/content/17/3/372.short [retrieved on 2011-08-01], abstract * |
| MICHAEL WEBER ET AL.: "Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells", NATURE GENETICS, vol. 37, no. 8, 1 August 2005 (2005-08-01), pages 853-862, XP002634922, NATURE PUBLISHING GROUP, NEW YORK, US ISSN: 1061-4036, DOI: 10.1038/NG1598 [retrieved on 2005-07-10], the whole document * |
| NimbleGen DNA Methylation: "2.1M Whole-genome Tiling and Deluxe promoter Arrays", NimbleGen web site, 31 December 2009 (2009-12-31), XP055003574, Retrieved from the Internet: URL:http://www.nimblegen.com/products/lit/methylation_datasheet_2.1m.pdf [retrieved on 2011-07-26], the whole document * |
| S.S.C. CHIM ET AL.: "Systematic Search for Placental DNA-Methylation Markers on Chromosome 21: Toward a Maternal Plasma-Based Epigenetic Test for Fetal Trisomy 21", CLINICAL CHEMISTRY, vol. 54, no. 3, 1 March 2008 (2008-03-01), pages 500-511, XP055003626, ISSN: 0009-9147, DOI: 10.1373/clinchem.2007.098731, the whole document * |
| V.K. RAKYAN ET AL.: "An integrated resource for genome-wide identification and analysis of human tissue-specific differentially methylated regions (tDMRs)", GENOME RESEARCH, vol. 18, no. 9, 1 January 2008 (2008-01-01), pages 1518-1529, XP055003620, ISSN: 1088-9051, DOI: 10.1101/gr.077479.108, the whole document * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018129293A1 (en) * | 2017-01-05 | 2018-07-12 | Diacarta Llc | Method for conducting early detection of colon cancer and/or of colon cancer precursor cells and for monitoring colon cancer recurrence |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20120107512A (ko) | 2012-10-02 |
| WO2011092592A3 (en) | 2011-11-03 |
| BR112012018458A2 (pt) | 2018-07-10 |
| CN102892899A (zh) | 2013-01-23 |
| PL2529032T3 (pl) | 2017-07-31 |
| US9249462B2 (en) | 2016-02-02 |
| CA2786174A1 (en) | 2011-08-04 |
| NZ601079A (en) | 2014-08-29 |
| US20120282613A1 (en) | 2012-11-08 |
| PT2529032T (pt) | 2017-05-04 |
| SG182322A1 (en) | 2012-08-30 |
| ES2623156T3 (es) | 2017-07-10 |
| JP2013517789A (ja) | 2013-05-20 |
| WO2011092592A2 (en) | 2011-08-04 |
| EA201290716A1 (ru) | 2013-06-28 |
| AU2011210255A1 (en) | 2012-07-26 |
| EP2529032B1 (en) | 2017-01-25 |
| AU2011210255B2 (en) | 2014-11-20 |
| CY1118864T1 (el) | 2018-01-10 |
| EP2529032A2 (en) | 2012-12-05 |
| DK2529032T3 (en) | 2017-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA023565B1 (ru) | Способы и композиции для неинвазивной пренатальной диагностики анеуплоидии плода | |
| JP6634105B2 (ja) | 非侵襲性の出生前診断のために有用な、母体サンプル由来の胎児核酸のメチル化に基づく濃縮のためのプロセスおよび組成物 | |
| JP6513622B2 (ja) | 非侵襲的出生前診断に有用な母体試料由来の胎児核酸のメチル化に基づく富化のためのプロセスおよび組成物 | |
| TWI806621B (zh) | 來自血漿之胚胎或腫瘤甲基化模式組(methylome)之非侵入性測定 | |
| Shah et al. | Comparison of cytogenetics and molecular karyotyping for chromosome testing of miscarriage specimens | |
| JP2018042580A (ja) | 非侵襲性の出生前診断に有用な母体サンプル由来の胎児核酸のメチル化に基づく富化のためのプロセスおよび組成物 | |
| AU2004274724A1 (en) | Methods and kits useful for detecting an alteration in a locus copy number | |
| US20210024999A1 (en) | Method of identifying risk for autism | |
| AU2017251674A1 (en) | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses | |
| Lim et al. | Novel epigenetic markers on chromosome 21 for noninvasive prenatal testing of fetal trisomy 21 | |
| KR102085667B1 (ko) | Gpr160 유전자의 메틸화 수준을 이용한 소혈관폐색증의 예측 또는 진단을 위한 정보제공방법 및 이를 위한 조성물 | |
| US20230151409A1 (en) | Methods and compositions for noninvasive prenatal diagnosis through targeted covalent labeling of genomic sites | |
| Fragkos et al. | Are expanded alleles of the FMR1 gene related to unexplained recurrent miscarriages? | |
| US20250140346A1 (en) | Sensitivity of tumor-informed minimal residual disease panels | |
| Kong et al. | Validation of a high-throughput and robust technique: BACs-on-beads assay (KaryoLite BoBs) for pre-implantation aneuploidy screening | |
| Mykytenko et al. | NGS-analysis of chorionic villi of miscarriages and conforming trophectoderm cells of transferred blastocysts | |
| Chow et al. | Validation of two whole genome amplification methods for PGD on monogenetic diseases and aneuploidy screening | |
| KR20250171839A (ko) | 대사이상 관련 지방간염 진단에 대한 정보 제공 방법 | |
| Vadgama | Investigating postzygotic de novo mutations and somatic mosaicism in monozygotic twins discordant for complex disorders | |
| Rakyan et al. | An integrated resource for genome-wide identification and analysis | |
| KR20200001030A (ko) | 태아의 염색체 이수성 판별용 프로브 세트 및 디지털 pcr을 이용한 태아의 염색체 이수성 판별 방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| TC4A | Change in name of a patent proprietor in a eurasian patent | ||
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AZ BY KZ KG MD TJ TM |